Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance

Daniel T Peters, Jacob Amburn, Sascha Tuchman, Eben I Lichtman, Christopher Edward Jensen, Koyal Jain, Suzanne Lentzsch, Rajshekhar Chakraborty, Divaya Bhutani, Samuel M Rubinstein

Blood (2023) 142 (Supplement 1): 2027.

https://doi.org/10.1182/blood-2023-189341

Published: 2023

Journal Articles

Performance of Newer Staging Systems for Myeloma in a Contemporary, Large Cohort of Patients in the United States

Ghulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji Kunnathu Kumar, S. Vincent Rajkumar, Rafael Fonseca, Nadine Abdallah, Greg Calip, Xiaoyan Wang, Christina Parrinello, Doug Sborov

Blood (2023) 142 (Supplement 1): 1068.

https://doi.org/10.1182/blood-2023-185136

Published: 2023

Journal Articles

Association of p16, a Biomarker of Cellular Senescence, with Receipt of Therapy for Plasma Cell Disorders

Christopher Edward Jensen, Shweta Srikanth, Allison M Deal, Sascha Alexander Tuchman, Natalia Mitin, Nicholas Mangieri, Samuel M Rubinstein, Kirsten A Nyrop, Hyman B Muss, Eben I Lichtman

Blood (2023) 142 (Supplement 1): 6619.

https://doi.org/10.1182/blood-2023-172437

Published: 2023

Journal Articles

A Cross-Sectional Analysis of County-Level Social Vulnerability and Physical Frailty Among Adults with Hematological Malignancies

Shakira J. Grant, Allison M. Deal, Hillary M. Heiling, Kirsten A Nyrop, Hyman B Muss, Samuel M. Rubinstein, Eben I Lichtman, Tanya M. Wildes, Sascha A. Tuchman

Blood (2021) 138 (Supplement 1): 4130.

https://doi.org/10.1182/blood-2021-149742

Published: 2021

Journal Articles

Thrombosis in the modern era of multiple myeloma

Samuel M. Rubinstein, Sascha A. Tuchman

Blood (2020) 136 (9): 1019–1021.

https://doi.org/10.1182/blood.2020006648

Published: 2020

Journal Articles

Correlation of Toll-like Receptor (TLR) and PD-1 Pathways in Central Nervous System Lymphoma: A Clinicopathological Study on Outcomes

Tarsheen Sethi, MD MBBS, Alexandra E. Kovach, MD, Samuel M Rubinstein, MD, Laura Lee, MDPhD, Yang Wang, PhD, David S. Morgan, MD, John P Greer, MD, Cindy Vnencak-Jones, PhD, Nishitha Reddy, MD MSCI, MBBS

Blood (2016) 128 (22): 929.

https://doi.org/10.1182/blood.V128.22.929.929

Published: 2016

Journal Articles

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Zhuoyan Li, MD, Samuel M Rubinstein, MD, Carey Clifton, ACNP, Leigh Ann Vaughan, ACNP, Melissa Logue, ACNP, Michael T. Byrne, DO, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Wichai Chinratanalab, MD, Salyka Sengsayadeth, MD, Stephen J. Brandt, MD, Stacey A. Goodman, MD MS, John P. Greer, MD, Madan Jagasia, MD, Bipin N. Savani, MD

Blood (2016) 128 (22): 3438.

https://doi.org/10.1182/blood.V128.22.3438.3438

Published: 2016

Journal Articles

Six-Minute Walk Test As a Measure of Functional Change after Chemotherapy in Cardiac AL Amyloidosis

Ilka Decker, MD MS, Oluchi C. Ukaegbu, MD, Stacey A. Goodman, MD MS, Daniel J. Lenihan, MD, Rebecca R Hung, MD, Adetola A. Kassim, MD MS, Shelton L. Harrell, MSN, ACNP-BC, Kevin McDonagh, MD, Sharon E. Phillips, MSPH, Kyle T Rawling, Samuel M Rubinstein, MD, Tarsheen K. Sethi, MD MS, Robert F Cornell, MD MS

Blood (2015) 126 (23): 1841.

https://doi.org/10.1182/blood.V126.23.1841.1841

Published: 2015

Journal Articles

The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6

Y Shabo, J Lotem, M Rubinstein, M Revel, SC Clark, SF Wolf, R Kamen, L Sachs

Blood (1988) 72 (6): 2070–2073.

https://doi.org/10.1182/blood.V72.6.2070.2070

Published: 1988

Journal Articles

Studies on Abnormal Hemoglobins : x. A New Syndrome: Hemoglobin C—Thalassemia Disease

KARL SINGER, ALFRED P. KRAUS, LILY SINGER, HERBERT M. RUBINSTEIN, SEYMOUR R. GOLDBERG

Blood (1954) 9 (11): 1032–1046.

https://doi.org/10.1182/blood.V9.11.1032.1032

Published: 1954

Journal Articles

Studies on Abnormal Hemoglobins : IX. Pure (Homozygous) Hemoglobin C Disease

KARL SINGER, A. ZERNE CHAPMAN, SEYMOUR R. GOLDBERG, HERBERT M. RUBINSTEIN, SOL A. ROSENBLUM

Blood (1954) 9 (11): 1023–1031.

https://doi.org/10.1182/blood.V9.11.1023.1023

Published: 1954

NARROW

Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance

Performance of Newer Staging Systems for Myeloma in a Contemporary, Large Cohort of Patients in the United States

Association of p16, a Biomarker of Cellular Senescence, with Receipt of Therapy for Plasma Cell Disorders

A Cross-Sectional Analysis of County-Level Social Vulnerability and Physical Frailty Among Adults with Hematological Malignancies

Thrombosis in the modern era of multiple myeloma

Correlation of Toll-like Receptor (TLR) and PD-1 Pathways in Central Nervous System Lymphoma: A Clinicopathological Study on Outcomes

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Six-Minute Walk Test As a Measure of Functional Change after Chemotherapy in Cardiac AL Amyloidosis

The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6

Studies on Abnormal Hemoglobins : x. A New Syndrome: Hemoglobin C—Thalassemia Disease

Studies on Abnormal Hemoglobins : IX. Pure (Homozygous) Hemoglobin C Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only